Title: Postdoctoral Research Scholar
PhD, Birla Institute of Technology and Science (BITS), Pilani, India
MPharmacy, IIT, Banaras Hindu University (BHU), Varanasi, India
BPharmacy, Madurai Medical College, The Tamil Nadu Dr MGR Medical University, Chennai, India.
Dr. Thirumurugan is a medicinal chemist in Dr. Slavko Komarnytsky’s laboratory. His main focus is the synthesis of phenolics and their metabolites, isolation and characterization of bioactive molecules, and also cell culture study using different cell lines.
Prior to joining PHHI in 2017, Dr. Thirumurugan spent 14 years in pharma industry and academia. He developed a few preclinical candidates for the treatment of cancer, such as Histone Deacetylase 1 inhibitor. He also developed nutritional supplements, including chilitenoids from red chili and zealutein from marigold flower. He has expertise in design and synthesis of small molecules for the treatment of MetS and also multistep synthesis of macrolides and ketolides. He has authored more than 25 scientific publications.
- Structural constraints and importance of caffeic acid moiety for anti‐hyperglycemic effects of caffeoylquinic acids from chicory, 2017
- Thiazolopyridines improve adipocyte function by inhibiting 11 beta-HSD1 oxoreductase activity, 2017
- Structural constraints and importance of caffeic acid moiety for anti-hyperglycemic effects of caffeoylquinic acids from chicory, 2017
- Bitter Receptors Control Glucose Absorption in the Gut by Modifying the G-protein Coupled Receptor Signaling Cascade, 2017